Key Highlights of the DECIDE Registry
The DECIDE Registry reveals new insights into how we manage coronary artery disease (CAD). Dr. Sarah Rinehart highlights how Heartflow Plaque Analysis adds critical detail beyond just coronary CTA (CCTA) alone, leading to changes in therapy for over half of patients1 and identifying opportunities for preventive care in those with non-obstructive disease.
By quantifying plaque and staging disease, Heartflow enables clinicians to tailor treatment more precisely, from monoclonal antibodies to lifestyle interventions. Watch to see how this approach is helping transform patient management and improve outcomes in everyday practice.
See CAD. Manage for life.
